Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

显示完整简历 隐藏完整简历

最新新闻和观点

Careers

Supporting regional talent growth with our new Cambridge training contracts

2022年9月30日

作者 Ross McNaughton

点击此处了解更多
公司/并购与资本市场

Advising Panmure Gordon on £6 million placing for biopharmaceutical group Arecor Therapeutics

2022年9月7日

作者 Ross McNaughton 以及 Tom Benjamin

点击此处了解更多
公司/并购与资本市场

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

2022年7月14日

作者

点击此处了解更多
公司/并购与资本市场

The AIM market: guides for US issuers

2022年4月27日

作者

点击此处了解更多

与我会面: